Clorox (NYSE:CLX) Price Target Lowered to $97.00 at Citigroup

Clorox (NYSE:CLXFree Report) had its price objective cut by Citigroup from $110.00 to $97.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a neutral rating on the stock.

Other equities analysts have also issued research reports about the stock. Barclays set a $85.00 price target on shares of Clorox in a research report on Friday. Royal Bank Of Canada lowered their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Rothschild & Co Redburn set a $117.00 price target on shares of Clorox in a research report on Friday, February 13th. Finally, UBS Group lowered their price target on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Clorox presently has an average rating of “Reduce” and a consensus target price of $104.93.

Get Our Latest Research Report on Clorox

Clorox Stock Down 9.7%

Shares of NYSE:CLX traded down $9.36 during midday trading on Friday, reaching $87.08. The company had a trading volume of 13,250,607 shares, compared to its average volume of 2,359,509. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The stock’s fifty day moving average price is $108.21 and its 200-day moving average price is $108.82. The stock has a market capitalization of $10.53 billion, a P/E ratio of 14.23, a PEG ratio of 0.48 and a beta of 0.65. Clorox has a one year low of $86.00 and a one year high of $140.24.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 379.46%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts expect that Clorox will post 5.87 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 5.7%. The ex-dividend date of this dividend is Wednesday, April 22nd. Clorox’s dividend payout ratio (DPR) is 81.05%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Clorox in the 4th quarter worth about $135,735,000. Van ECK Associates Corp increased its position in shares of Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Invesco Ltd. lifted its holdings in Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Clorox by 6,907.9% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after buying an additional 739,005 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC acquired a new position in Clorox in the second quarter valued at about $71,856,000. 78.53% of the stock is owned by institutional investors.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Q3 results beat on the bottom line as cost cuts and lower spending lifted non?GAAP EPS to $1.64, above estimates, showing operational leverage despite flat sales. Read More.
  • Positive Sentiment: Management is emphasizing innovation and strategic moves to drive future growth — a narrative investors may watch if execution improves. Read More.
  • Neutral Sentiment: The company provided Q3 filings, an earnings call transcript and a formal press release; these sources contain details on segment trends and cost actions for modeling. Read More.Read More.
  • Negative Sentiment: Clorox trimmed FY?2026 guidance (EPS and sales), citing weaker demand and market?share headwinds — management’s guidance was well below consensus, which is the main catalyst for the selloff. Read More.
  • Negative Sentiment: Several large brokers cut price targets and shifted to neutral/underweight after the update (Morgan Stanley, Citi, JPMorgan, Wells Fargo), increasing short?term selling pressure. Read More.Read More.
  • Negative Sentiment: A shareholder law firm announced an investigation into possible securities?fraud claims related to Clorox’s statements, adding regulatory/legal risk that can weigh on sentiment. Read More.
  • Negative Sentiment: Shares hit new 52?week lows and traded at much higher volumes, signaling broad repositioning by investors and momentum that could continue until clarity on sales/margin recovery arrives. Read More.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.